| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.849 | 12.039 | 18.825 | 10.873 | 13.194 | 5.311 | 0 | 13.600 |
| Total Income - EUR | - | - | 4.849 | 12.039 | 18.825 | 10.873 | 13.194 | 5.716 | 0 | 13.600 |
| Total Expenses - EUR | - | - | 3.708 | 10.594 | 15.146 | 11.008 | 10.282 | 5.604 | 795 | 13.564 |
| Gross Profit/Loss - EUR | - | - | 1.140 | 1.445 | 3.678 | -135 | 2.912 | 113 | -795 | 36 |
| Net Profit/Loss - EUR | - | - | 1.033 | 1.325 | 3.490 | -221 | 2.878 | 86 | -795 | 36 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Floredent Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 2.784 | 2.410 | 2.043 | 1.734 | 1.414 | 1.094 |
| Current Assets | - | - | 1.165 | 3.357 | 4.992 | 3.720 | 8.310 | 6.044 | 6.026 | 7.593 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 3.194 | 1.396 | 2.502 | 2.495 | 2.481 |
| Cash | - | - | 1.165 | 3.357 | 4.992 | 526 | 6.914 | 3.542 | 3.531 | 5.112 |
| Shareholders Funds | - | - | 1.143 | 2.447 | 5.889 | 5.556 | 8.310 | 7.980 | 7.161 | 6.896 |
| Social Capital | - | - | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | 23 | 911 | 1.887 | 574 | 2.042 | 280 | 279 | 1.791 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Floredent Medical S.r.l.